BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9738151)

  • 1. Conflicts of interest. Research gone bad?
    Serb C
    Hosp Health Netw; 1998 Aug 5-20; 72(15-16):76. PubMed ID: 9738151
    [No Abstract]   [Full Text] [Related]  

  • 2. Full disclosure of financial interests in biomedical publications--a reminder.
    Bailey BJ
    Laryngoscope; 2002 Feb; 112(2):211-2. PubMed ID: 11889370
    [No Abstract]   [Full Text] [Related]  

  • 3. Conflicts of interest: the responsibility of the authors and editors of the International Journal of Cancer.
    zur Hausen H; Bartsch H; Fusenig N; Doeberitz Mv; Kyewski B; Lichter P; Miller A
    Int J Cancer; 2006 Jun; 118(12):2919. PubMed ID: 16482565
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Pharmacology & Therapeutics' conflict of interest policy.
    ;
    Clin Pharmacol Ther; 2007 Nov; 82(5):496-7. PubMed ID: 17952103
    [No Abstract]   [Full Text] [Related]  

  • 5. From disclosure to transparency to action.
    Rockey DC
    Arch Intern Med; 2011 Jan; 171(1):94-5. PubMed ID: 21220671
    [No Abstract]   [Full Text] [Related]  

  • 6. Does Clinical Pharmacology & Therapeutics' conflict of interest policy protect the reader?
    Conway MH
    Clin Pharmacol Ther; 2007 Nov; 82(5):495-6. PubMed ID: 17952102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery journal threatens ban for authors' hidden conflicts.
    Armstrong D
    Wall St J (East Ed); 2005 Dec; ():B1, B2. PubMed ID: 16502542
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung cancer screening trial financed by tobacco-funded foundation, sparks debate.
    Twombly R
    J Natl Cancer Inst; 2008 May; 100(10):690-1. PubMed ID: 18477793
    [No Abstract]   [Full Text] [Related]  

  • 9. Disclosure of research funds.
    Axtens M
    Aust Fam Physician; 1998 Jul; 27 Suppl 2():S112. PubMed ID: 9679368
    [No Abstract]   [Full Text] [Related]  

  • 10. From disclosure to transparency: the use of company payment data.
    Chimonas S; Frosch Z; Rothman DJ
    Arch Intern Med; 2011 Jan; 171(1):81-6. PubMed ID: 20837820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology & therapeutics--an update.
    Stein CM
    Clin Pharmacol Ther; 2003 Jan; 73(1):1-3. PubMed ID: 12545137
    [No Abstract]   [Full Text] [Related]  

  • 12. Conflict of interest: in the eye of the beholder?
    Chabner BA
    Oncologist; 2008 Mar; 13(3):212-3. PubMed ID: 18378530
    [No Abstract]   [Full Text] [Related]  

  • 13. Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners.
    Johnston KL; Go RS
    J Natl Cancer Inst; 2007 Sep; 99(18):1415-6. PubMed ID: 17848676
    [No Abstract]   [Full Text] [Related]  

  • 14. Our conflicted medical journals.
    N Y Times Web; 2006 Jul; ():WK11. PubMed ID: 16906684
    [No Abstract]   [Full Text] [Related]  

  • 15. Getting the whole story. Don't assume that all published research is objective.
    Burda D
    Mod Healthc; 2005 Feb; 35(7):30. PubMed ID: 15736796
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical reviews face criticism over lapses.
    Armstrong D
    Wall St J (East Ed); 2006 Jul; ():B1, B2. PubMed ID: 16909499
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicine in the Noise Age: what can we believe?
    Angell M
    Account Res; 2001; 8(3):189-95. PubMed ID: 12481786
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflicts of interest--in publishing and in practice.
    Young D
    Birth; 2004 Jun; 31(2):81-3. PubMed ID: 15153125
    [No Abstract]   [Full Text] [Related]  

  • 19. Caveat lector.
    Gershen BJ
    Md Med; 2007; 8(1):15-6. PubMed ID: 17472148
    [No Abstract]   [Full Text] [Related]  

  • 20. Tough-talking journal editor faces accusations of leniency.
    McNeil DG
    N Y Times Web; 2006 Aug; ():F1, F3. PubMed ID: 16906685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.